Literature DB >> 17678722

Association between RANTES polymorphisms and asthma severity among Tunisian children.

Jihene Lachheb1, Hanene Chelbi, Kamel Hamzaoui, Agnès Hamzaoui.   

Abstract

The chemokine known as RANTES (regulated upon activation, normal T cells expressed and secreted) is an important element for the chemotaxis at the site of allergic inflammation. Many studies have made an interesting link between RANTES polymorphisms and asthma, showing that the variant in the promoter region is associated with high risk of asthma and severe airway obstruction. We conducted a case-control and family study aiming at identifying the relationship between polymorphisms (-28 C/G and -403 G/A) and haplotypes in the RANTES gene with asthma and severity. The results of the case control study suggest an association between alleles level of -28 C/G and -403 G/A promoter polymorphism (p = 0.01) (p = 0.00175) and asthma. Univariate analysis of the RANTES polymorphisms show an increased prevalence of the AC and AG haplotypes in asthmatics (p = 0.014) and (p = 0.015) respectively. Our data suggest that -28 C/G and -403 G/A polymorphisms within the RANTES promoter region play an important role in asthma predisposition and in the severity of airway obstruction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678722     DOI: 10.1016/j.humimm.2007.04.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

Review 2.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

3.  J774 macrophage-like cell line cytokine and chemokine patterns are modulated by Francisella tularensis LVS strain infection.

Authors:  M Holicka; J Novosad; M Kudlova; M Loudova; C Andrys; J Krejsek
Journal:  Folia Microbiol (Praha)       Date:  2010-05-19       Impact factor: 2.099

4.  Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and asthma risk--a meta-analysis.

Authors:  Qiaoqiao Fang; Furu Wang; Deyu Zhao
Journal:  Int J Med Sci       Date:  2010-02-10       Impact factor: 3.738

Review 5.  The regulated upon activation normal T-cell expressed and secreted (RANTES) -28C/G and -403G/A polymorphisms and asthma risk: a meta-analysis.

Authors:  Zi-Kang Xie; Hua Zhao; Jian Huang; Zheng-Fu Xie
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

6.  Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection.

Authors:  Clare A Stokes; Saila Ismail; Emily P Dick; Julie A Bennett; Sebastian L Johnston; Michael R Edwards; Ian Sabroe; Lisa C Parker
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Study of the association between -403G/A and -28C/G RANTES gene polymorphisms and asthma in Lebanon.

Authors:  Rana Nahas; Hana M Fakhoury; Hania N Chmaisse; Rajaa F Makki
Journal:  Ann Thorac Med       Date:  2012-01       Impact factor: 2.219

8.  The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study.

Authors:  Haïfa Maalmi; Anissa Berraïes; Eya Tangour; Jamel Ammar; Hanadi Abid; Kamel Hamzaoui; Agnes Hamzaoui
Journal:  J Asthma Allergy       Date:  2012-05-09

9.  Association between RANTES gene polymorphisms and asthma: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

10.  Association of RANTES gene polymorphisms with susceptibility to childhood asthma: A meta-analysis.

Authors:  Yan-Qin Zhang; Xiu-Xiang Gao
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.